Clinical Trial Update: Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated safety and immunogenicity of a booster dose of pneumococcal conjugate vaccine in preterm born infants; results completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal
• Pneumococcal Infections
• Streptococcus Pneumoniae Infections

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2017-04-12